We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans

By MedImaging International staff writers
Posted on 02 Sep 2025
Image: Patch-based deep-learning model with limited training dataset for liver tumor segmentation in contrast-enhanced hepatic CT (Yang et al. (2025), IEEE Access, 10.1109/ACCESS.2025.3570728)
Image: Patch-based deep-learning model with limited training dataset for liver tumor segmentation in contrast-enhanced hepatic CT (Yang et al. (2025), IEEE Access, 10.1109/ACCESS.2025.3570728)

Liver cancer is the sixth most common cancer worldwide and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is critical for diagnosis and therapy, but manual methods by radiologists are time-consuming and prone to variations in expertise. Artificial intelligence (AI)-based segmentation has advanced the field, yet most models require thousands of cases for training, creating a barrier to adoption. Now, a groundbreaking AI model has shown high accuracy even with limited training datasets.

Researchers at the Institute of Science Tokyo (Tokyo, Japan) have developed the Multi-scale Hessian-enhanced Patch-based Neural Network (MHP-Net), a deep learning model for liver tumor segmentation. Instead of analyzing entire scans at once, MHP-Net divides images into 3D patches and pairs them with enhanced versions using Hessian filtering, which highlights spherical features like tumors. This architecture creates precise segmentation maps from contrast-enhanced CT scans.

The model’s accuracy was evaluated using Dice similarity scores, which measure overlap between predicted and expert-annotated tumor boundaries. Despite training on datasets as small as 7, 14, and 28 tumors, MHP-Net achieved Dice scores of 0.691, 0.709, and 0.719, respectively. The findings, published in IEEE Access, show the model outperformed established AI systems such as U-Net, Res U-Net, and HDense-U-Net.

In addition to its accuracy, MHP-Net’s lightweight design allows training in under 10 minutes and real-time inference in about four seconds per patient, making it suitable for clinical use with limited computing power. By reducing data requirements, it opens AI adoption to under-resourced hospitals worldwide. Researchers plan to expand the model’s applications, exploring small-data AI solutions for rare cancers and broader medical imaging challenges.

“This is just a start in the field of small-data AI, where meaningful and clinically relevant deep learning models can be built from limited datasets,” said Professor Kenji Suzuki, who led the development of the model. “MHP-Net’s success can inspire small-data AI solutions in other areas of medical imaging as well, such as the detection of rare cancers.”

Related Links:
Institute of Science Tokyo

High-Precision QA Tool
DEXA Phantom
Radiation Safety Barrier
RayShield Intensi-Barrier
Mobile X-Ray System
K4W
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Channels

Ultrasound

view channel
Image: The super-resolution lymphatic imaging system could diagnose and monitor patients with lymphatic disease (Photo courtesy of Adobe Stock)

Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time

Lymphatic disorders affect hundreds of millions of people worldwide and are linked to conditions ranging from limb swelling and organ dysfunction to birth defects and cancer-related complications.... Read more

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.